Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
about
The rise of food allergy: Environmental factors and emerging treatmentsUpdate on Early Nutrition and Food Allergy in ChildrenRecent advances in immunotherapy and vaccine development for peanut allergyInnate and adaptive dendritic cell responses to immunotherapyBasic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy.Epigenetics and development of food allergy (FA) in early childhood.A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.Cord blood T cell subpopulations and associations with maternal cadmium and arsenic exposures.Regulatory T cells and their roles in immune dysregulation and allergy.Mechanisms of allergic disease - environmental and genetic determinants for the development of allergy.Suppression of the immunologic response to peanut during immunotherapy is often transient.The role of gene-environment interactions in the development of food allergy.Orally-Induced Intestinal CD4+ CD25+ FoxP3+ Treg Controlled Undesired Responses towards Oral Antigens and Effectively Dampened Food Allergic Reactions.Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.Molecular and cellular mechanisms of food allergy and food tolerance.Naturally occurring tolerance acquisition to foods in previously allergic children is characterized by antigen specificity and associated with increased subsets of regulatory T cells.Improvement of Therapeutic Efficacy of Oral Immunotherapy in Combination with Regulatory T Cell-Inducer Kakkonto in a Murine Food Allergy ModelCritical role of intestinal interleukin-4 modulating regulatory T cells for desensitization, tolerance, and inflammation of food allergy.Data-driven programmatic approach to analysis of basophil activation tests.Single B-cell deconvolution of peanut-specific antibody responses in allergic patientsSuccessful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets.Diagnosis, management, and investigational therapies for food allergies.Toward precision medicine and health: Opportunities and challenges in allergic diseasesSublingual (SLIT) versus oral immunotherapy (OIT) for food allergyThe Role of Skin Barrier in the Pathogenesis of Food AllergyRegulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy.Induced regulatory T cells in allograft tolerance via transient mixed chimerism.Food allergy: immune mechanisms, diagnosis and immunotherapyOral immunotherapy for food allergy: mechanisms and role in management.Immune mechanisms of sublingual immunotherapy.Peanut immunotherapy.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Oral immunotherapy for the treatment of food allergy.The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.Developing therapies for peanut allergy.The future of biologics: applications for food allergy.Current developments for improving efficacy of allergy vaccines.Is clinical tolerance possible after allergen immunotherapy?An Examination of Clinical and Immunologic Outcomes in Food Allergen Immunotherapy by Route of Administration.
P2860
Q26744294-E7CA1959-B71D-4C0C-B543-6406BEED2294Q26753181-3F1E93AA-A1EF-4F34-8C89-D64F750CF16FQ26796442-CEE576D5-2E56-43DF-A9C6-4CF6119E3D8BQ28081972-B10161CB-F0E6-4CF4-BE60-2F5FC0CC1E79Q30276174-1F8452EE-16E4-450E-826B-DD845A516259Q30300277-32C3FAC8-BA4F-45D5-B05F-4184F135F850Q33358887-3FA70B00-D58F-4694-8BBC-3C475D2D656FQ33574876-C0C9C3F4-73AD-4B20-B9F0-3232B90864CAQ33852990-EEB194EC-F070-4014-8C68-23C93968D8C5Q34166571-29181706-BD3D-479B-BAB3-5EC35177F435Q35577604-46737037-F794-4C50-9679-709CD1CA2366Q35589449-2DE6EBAA-3CEF-4642-8AA2-0C4367E03D77Q35769726-586DD8BA-6F48-4001-AEA2-F251809A3FFCQ35827532-F4CF489A-19A4-45AF-9160-6DAF6A384B83Q35939076-1A63F539-8A45-43DB-83D8-1865588ECFE6Q35984123-CA00A5FE-FAB0-4E55-A25C-6AE7551F578FQ36167100-9363D692-C1CD-4594-BF56-8C0AE0880569Q36256005-955DBFCE-1E74-46ED-854B-EF78825F9E64Q36289817-712CCAA2-2897-4FAB-8F5B-C5F7B198E583Q36406527-5F481AD5-3142-4CEA-BF05-7115C01560DDQ36426385-4B6BECC9-C2C9-45BC-A20D-9D46F5C439DBQ36658984-3AA4835A-CD61-43A2-96D5-3E8214A444F3Q36692411-5E56D53A-5A3E-4151-92FB-616D3387BDCFQ36916201-5F552998-54FC-406D-B878-EABA78CEF977Q36966224-CCDF45FB-3A5C-4E44-A6C3-461EDD4A8327Q37055921-1F8CD9A7-5E34-4425-A498-39E1760927CAQ37089231-47D0D927-D77D-4E1D-88AE-130B57BC27A1Q37109198-98B7A8F5-F448-4F73-AB6A-A7D6EFD503E5Q37442005-DF4F8DCB-C32B-4520-9A19-26FE0F4FAA90Q38235447-35855EB2-0169-4052-9E79-C88C592CAFF5Q38246584-89969E49-9382-41D2-B08A-D30850A2E14EQ38256162-CBE662AD-A47D-4B46-BCEE-DAC39519A7A9Q38259275-0105C67F-3C38-4914-BDAD-4457E824D9BFQ38271442-B7CA97B3-3AA8-4DDE-A466-7DE30708BB42Q38278145-43A75356-AD60-4511-A9E1-B9367F7F3D98Q38296706-2CBB5273-793A-4916-9E2B-E3168EF282F2Q38348057-948E3DBF-6AA0-4520-AA7D-B3B6AA9027B2Q38503330-90E3776A-6BE6-46BC-9918-3B456841CC0BQ38542313-1DA3120A-44E8-49B2-B98F-75AD95FC9349Q38542587-E9CA087B-C3C6-4887-9671-3D71D1F38D8C
P2860
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@ast
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@en
type
label
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@ast
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@en
prefLabel
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@ast
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@en
P2093
P2860
P1476
Peanut oral immunotherapy resu ...... orkhead box protein 3 (FOXP3).
@en
P2093
Aleena Syed
Arunima Kohli
Gerri O'Riordan
Holden Maecker
Jelena P Berglund
Kari C Nadeau
Marco A Garcia
Mindy Tsai
Robert Bucayu
Satoru Ishida
P2860
P304
P356
10.1016/J.JACI.2013.12.1037
P407
P577
2014-02-01T00:00:00Z